Alvotech Logo

Alvotech

ALVOW

(2.2)
Stock Price

2,97 USD

-59.64% ROA

69.49% ROE

-5.81x PER

Market Cap.

3.874.043.700,00 USD

-176.02% DER

0% Yield

-120.14% NPM

Alvotech Stock Analysis

Alvotech Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Alvotech Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (84.2%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-4.19x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-189%), which means it has a small amount of debt compared to the ownership it holds

4 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

5 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

6 ROA

The stock's ROA (-47.01%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-2), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Alvotech Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Alvotech Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Alvotech Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Alvotech Revenue
Year Revenue Growth
2019 31.918.000
2020 66.616.000 52.09%
2021 36.772.000 -81.16%
2022 83.029.000 55.71%
2023 71.156.000 -16.69%
2023 91.434.000 22.18%
2024 213.928.000 57.26%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Alvotech Research and Development Expenses
Year Research and Development Expenses Growth
2019 95.557.000
2020 148.072.000 35.47%
2021 191.006.000 22.48%
2022 180.622.000 -5.75%
2023 212.924.000 15.17%
2023 210.827.000 -0.99%
2024 190.444.000 -10.7%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Alvotech General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 48.566.000
2020 58.914.000 17.56%
2021 84.134.000 29.98%
2022 186.742.000 54.95%
2023 66.592.000 -180.43%
2023 76.559.000 13.02%
2024 56.264.000 -36.07%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Alvotech EBITDA
Year EBITDA Growth
2019 -48.113.000
2020 -125.670.000 61.71%
2021 -168.110.000 25.25%
2022 -326.074.000 48.44%
2023 -158.004.000 -106.37%
2023 -334.637.000 52.78%
2024 -183.388.000 -82.47%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Alvotech Gross Profit
Year Gross Profit Growth
2019 31.918.000
2020 66.616.000 52.09%
2021 36.772.000 -81.16%
2022 18.934.000 -94.21%
2023 -74.956.000 125.26%
2023 -69.422.000 -7.97%
2024 33.088.000 309.81%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Alvotech Net Profit
Year Net Profit Growth
2019 -209.876.000
2020 -170.044.000 -23.42%
2021 -101.504.000 -67.52%
2022 -513.580.000 80.24%
2023 -753.280.000 31.82%
2023 -551.731.000 -36.53%
2024 260.900.000 311.47%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Alvotech Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 -1
2020 -5 100%
2021 -3 -66.67%
2022 -3 -50%
2023 -3 33.33%
2023 -2 -50%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Alvotech Free Cashflow
Year Free Cashflow Growth
2019 -96.600.000
2020 -86.277.000 -11.96%
2021 -268.803.000 67.9%
2022 -361.391.000 25.62%
2023 -358.658.000 -0.76%
2023 -127.673.000 -180.92%
2024 -57.686.000 -121.32%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Alvotech Operating Cashflow
Year Operating Cashflow Growth
2019 -88.548.000
2020 -74.295.000 -19.18%
2021 -228.170.000 67.44%
2022 -312.389.000 26.96%
2023 -312.185.000 -0.07%
2023 -117.020.000 -166.78%
2024 -50.597.000 -131.28%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Alvotech Capital Expenditure
Year Capital Expenditure Growth
2019 8.052.000
2020 11.982.000 32.8%
2021 40.633.000 70.51%
2022 49.002.000 17.08%
2023 46.473.000 -5.44%
2023 10.653.000 -336.24%
2024 7.089.000 -50.28%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Alvotech Equity
Year Equity Growth
2020 -867.243.000
2021 -135.612.000 -539.5%
2022 -564.416.000 75.97%
2023 -660.852.000 14.59%
2023 -932.493.000 29.13%
2024 -605.922.000 -53.9%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Alvotech Assets
Year Assets Growth
2020 474.422.000
2021 597.977.000 20.66%
2022 828.443.000 27.82%
2023 958.819.000 13.6%
2023 950.090.000 -0.92%
2024 1.068.478.000 11.08%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Alvotech Liabilities
Year Liabilities Growth
2020 1.341.665.000
2021 733.589.000 -82.89%
2022 1.392.859.000 47.33%
2023 1.619.671.000 14%
2023 1.882.583.000 13.97%
2024 1.674.400.000 -12.43%

Alvotech Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.49
Net Income per Share
-2.21
Price to Earning Ratio
-5.81x
Price To Sales Ratio
28.26x
POCF Ratio
-11.58
PFCF Ratio
-11.29
Price to Book Ratio
-5.93
EV to Sales
36.85
EV Over EBITDA
-18.86
EV to Operating CashFlow
-16.29
EV to FreeCashFlow
-14.73
Earnings Yield
-0.17
FreeCashFlow Yield
-0.09
Market Cap
3,87 Bil.
Enterprise Value
5,05 Bil.
Graham Number
10.39
Graham NetNet
-5.36

Income Statement Metrics

Net Income per Share
-2.21
Income Quality
0.5
ROE
0.87
Return On Assets
-0.36
Return On Capital Employed
-0.04
Net Income per EBT
0.92
EBT Per Ebit
10.6
Ebit per Revenue
-0.12
Effective Tax Rate
0.08

Margins

Sales, General, & Administrative to Revenue
0.47
Research & Developement to Revenue
1.52
Stock Based Compensation to Revenue
0.08
Gross Profit Margin
0.56
Operating Profit Margin
-0.12
Pretax Profit Margin
-1.31
Net Profit Margin
-1.2

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-1.11
Free CashFlow per Share
-1.23
Capex to Operating CashFlow
-0.11
Capex to Revenue
0.24
Capex to Depreciation
1.17
Return on Invested Capital
-0.59
Return on Tangible Assets
-0.6
Days Sales Outstanding
414.05
Days Payables Outstanding
135.2
Days of Inventory on Hand
222.94
Receivables Turnover
0.88
Payables Turnover
2.7
Inventory Turnover
1.64
Capex per Share
0.12

Balance Sheet

Cash per Share
0,04
Book Value per Share
-2,17
Tangible Book Value per Share
-2.28
Shareholders Equity per Share
-2.17
Interest Debt per Share
5.08
Debt to Equity
-1.76
Debt to Assets
1
Net Debt to EBITDA
-4.4
Current Ratio
0.24
Tangible Asset Value
-0,64 Bil.
Net Current Asset Value
-1,39 Bil.
Invested Capital
-508035000
Working Capital
-0,92 Bil.
Intangibles to Total Assets
0.03
Average Receivables
0,11 Bil.
Average Payables
0,05 Bil.
Average Inventory
94405000
Debt to Market Cap
0.28

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Alvotech Dividends
Year Dividends Growth

Alvotech Profile

About Alvotech

Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.

CEO
Mr. Robert Wessman
Employee
999
Address
Saemundargata 15-19
Reykjavik, 102

Alvotech Executives & BODs

Alvotech Executives & BODs
# Name Age
1 Mr. Robert Wessman
Chief Executive Officer, Founder & Executive Chairman
70
2 Mr. Faysal Kalmoua
Chief Operating Officer & Director
70
3 Mr. Joel Morales
Chief Financial Officer
70
4 Mr. Giedrius Zunda
Chief Technical Officer
70
5 Mr. Joseph E. McClellan
Chief Scientific Officer
70
6 Ms. Tanya Zharov
General Counsel
70
7 Ms. Jenny Sif Steingrimsdottir
Vice President of People & Culture
70
8 Mr. Anil Okay
Chief Commercial Officer
70
9 Mr. Ming Li
Chief Strategy Officer
70
10 Ms. Christina Siniscalchi
Chief Quality Officer
70

Alvotech Competitors